For a fixed value of M, the constellation can be optimized through the minimization of a suitably defined cost function, or, equivalently, through the maximization of a quantity related to the cost function.
Convexity of a suitably defined cost function is studied, indicating that parameter estimation can be accomplished using standard optimization techniques.
The basic initial point in cost-center accounting, defined by law for all German hospitals, is a defined set of cost-centers and cost categories.
Secondly, results were categorised according to a defined set of cost effectiveness thresholds: WHO-CHOICE denotes as "cost effective" an intervention that produces a healthy year of life for less than three times the GDP per capita, and as "very cost effective" an intervention that produces a healthy year of life for less than GDP per capita.
Secondly, we categorised results according to a defined set of cost effectiveness thresholds: WHO-CHOICE denotes an intervention as "cost effective" if it produces a healthy year of life for less than three times the gross domestic product (GDP) per capita, and as "very cost effective" if it produces a healthy year of life for less than the GDP per capita.
It could be argued that recent experimental evidence shows no bias in the second base ([ 13, 63] but more data is needed for reliable conclusions, so we adhered to the traditional scheme that was chosen a priori, before performing any simulations and numerical experiments. The matrix d(a(c), a(c')) defines the cost of replacing amino acid a(c) with amino acid a(c').
Posaconazole is considered cost-effective relative to fluconazole when the incremental cost per QALY gained is below a defined ceiling ratio of cost-effectiveness.
Questions on RIS/PACS cost-effectiveness should not only be answered by comparing operating costs over a defined period of time and setting them in relation to the investment costs (statically or dynamically).
Differences observed (on the basis of cost per unit administration) disappear, are attenuated or reversed when one considers drug administration costs over a defined period of time.
As an example, for NPH and regular therapy combination, if NPH and regular insulin consumption accounted for 65%and35%5% of the total consumption of NPH and regular in a defined year, one DDD cost of this therapy combination was calculated as 0.65 of one DDD of NPH plus 0.35 of one DDD of regular insulin for that year.
The distance d(a(c), a(c')) in (1) defines the cost of replacing amino acid a(c) with amino acid a(c').
